Methods for adjuvant free hepatitis A virus vaccination
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 10, 2000
Grant Date -
N/A
app pub date -
Feb 8, 1996
filing date -
Aug 12, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention provides the use of Hepatitis A virus capsid, or a mucosally immunogenic fragment or epitope thereof, for the manufacture of a mucosal vaccine composition for administration to a mucosal surface of a patient to induce production of serum Immunoglobulin G antibody against Hepatitis A. Preferably the vaccine composition is administered by the intranasal route.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully